Serotonin and the Vascular System
Authors:
- 1 February 1986
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 31 (2) , 149-163
Abstract
Serotonin released from aggregating platelets can reach sufficient concentrations to affect local vascular function in a number of ways. The monoamine can cause contraction of blood vessels by its direct action on smooth muscle or by potentiating the effect of other vasoconstrictor agents. It can also induce vasodilatation by a direct relaxing effect on smooth muscle, by inhibition of adrenergic nerves, and by release of an uncharacterised relaxing factor from endothelial cells. One of its most likely physiological roles is to aid in haemostasis by promoting platelet aggregation and by causing local vasoconstriction at sites of injury. It probably has a role in some forms of vascular pathology as well: it may contribute to vasospasm of cerebral, coronary, and digital arteries, particularly if there is endothelial dysfunction or damage. Much evidence has implicated serotonin (5-hydroxytryptamine) in the pathogenesis of migraine. Serotonergic agonists, such as ergotamine, and antagonists, such as methys-ergide and pizotifen, are both used in therapy of migraine. Promising but conflicting early results have not yet defined a place for serotonergic antagonists in other vasospastic disorders. The antihypertensive efficacy of one serotonergic antagonist, ketanserin, raises questions about the possible involvement of serotonin in either the initiation or the maintenance of the elevated peripheral vascular resistance in several forms of hypertension, including essential hypertension.Keywords
This publication has 95 references indexed in Scilit:
- Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?Circulation, 1984
- Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis.Circulation, 1984
- 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.Hypertension, 1984
- Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.Hypertension, 1983
- Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: α-adrenoceptors are not involvedBasic Research in Cardiology, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Review of the role of the central serotonergic neuronal system in blood pressure regulation.Hypertension, 1980
- Similarities of ergonovine-induced and spontaneous attacks of variant angina.Circulation, 1979
- Vascular reactivity in hypertensive rats after treatment with anti-hypertensive agentsLife Sciences, 1974
- Pizotifen (BC-105)Drugs, 1972